S0307A, Long-Term Bone Quality in Women With Breast Cancer Enrolled on Clinical Trial SWOG-S0307
Withdrawn before enrolling
Conditions studied: Breast Cancer
In brief
RATIONALE: Gathering information over time from imaging and laboratory tests of women receiving bisphosphonates for breast cancer may help doctors learn more about long-term bone quality and plan the best treatment. Tetracycline hydrochloride and demeclocycline hydrochloride can mark the new growth of the bone, so it may be seen better under a microscope. PURPOSE: This clinical trial is studying long-term bone quality in women with breast cancer enrolled on clinical trial SWOG-S0307.
Key facts
- Study ID
- NCT00873808
- Run by
- SWOG Cancer Research Network
- People needed
- 0
- Starts
- 2008-10-01
- Expected to finish
- 2010-02-01
- Last updated by the study team
- 2013-04-10
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- University Cancer Center at University of Washington Medical Center — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.